• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Parkinsons drug

Anonymous

Guest
With you guys bringing the Cephalon CNS sales reps over, how much more voice and messaging do you need with Azilect since it's a 2nd position drug for you? Is there still a big need for more people detailing that product?
 

<